Massive Bio Company
Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
Investors
.jpeg)
Technology:
Artificial Intelligence, Big Data, Biotechnology, Clinical Trials, Genetics, Machine Learning, Medical, Pharmaceutical
Industry:
AI, Clinical Development, United States
Headquarters:
New York, New York, United States
Founded Date:
2015-05-04
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
13
Total Funding:
23317500
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-06-02
Last Funding Type:
Series B
Register and Claim Ownership